Does MONTELUKAST Cause Tonsillar hypertrophy? 12 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 12 reports of Tonsillar hypertrophy have been filed in association with MONTELUKAST (Montelukast). This represents 0.0% of all adverse event reports for MONTELUKAST.
12
Reports of Tonsillar hypertrophy with MONTELUKAST
0.0%
of all MONTELUKAST reports
0
Deaths
2
Hospitalizations
How Dangerous Is Tonsillar hypertrophy From MONTELUKAST?
Of the 12 reports, 2 (16.7%) required hospitalization, and 1 (8.3%) were considered life-threatening.
Is Tonsillar hypertrophy Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for MONTELUKAST. However, 12 reports have been filed with the FAERS database.
What Other Side Effects Does MONTELUKAST Cause?
Asthma (8,372)
Dyspnoea (6,354)
Wheezing (5,159)
Drug ineffective (3,539)
Cough (3,475)
Therapeutic product effect incomplete (3,352)
Anxiety (2,994)
Loss of personal independence in daily activities (2,736)
Sleep disorder due to a general medical condition (2,101)
Obstructive airways disorder (2,073)
What Other Drugs Cause Tonsillar hypertrophy?
ADALIMUMAB (151)
ONDANSETRON (51)
SOMATROPIN (43)
SECUKINUMAB (42)
DUPILUMAB (39)
METHOTREXATE (39)
INFLIXIMAB (31)
TACROLIMUS (26)
INFLIXIMAB-DYYB (25)
ETANERCEPT (24)
Which MONTELUKAST Alternatives Have Lower Tonsillar hypertrophy Risk?
MONTELUKAST vs MONTELUKAST\MONTELUKAST
MONTELUKAST vs MONTMORILLONITE
MONTELUKAST vs MORNIFLUMATE
MONTELUKAST vs MOROCTOCOG ALFA
MONTELUKAST vs MORPHINE